G V Papatheodoridis Selected Research

G V Papatheodoridis Research Topics

Disease

17	Chronic Hepatitis B 01/2018 - 10/2000
16	Fibrosis (Cirrhosis) 02/2016 - 08/2000
9	Chronic Hepatitis C 11/2010 - 07/2004
4	Infections 07/2010 - 09/2001
4	Hepatitis 01/2008 - 08/2000
3	Hepatitis B 02/2013 - 01/2004
2	Hepatocellular Carcinoma (Hepatoma) 02/2015 - 05/2001
2	Insulin Resistance 11/2010 - 11/2009
2	Hemorrhage 05/2007 - 08/2006
2	Hepatitis C 05/2001 - 08/2000
1	Pain (Aches) 07/2017
1	Rectal Prolapse 07/2017
1	Inflammation (Inflammations) 11/2010
1	Necrosis 07/2010
1	Rheumatic Diseases (Rheumatism) 07/2010
1	Glucose Intolerance 06/2009
1	Non-alcoholic Fatty Liver Disease 04/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2008
1	Alcoholic Fatty Liver 01/2008
1	Hemophilia A (Haemophilia) 05/2007
1	Varicose Veins (Varicose Vein) 08/2006
1	Portal Hypertension 07/2006
1	Diabetes Mellitus 05/2006
1	End Stage Liver Disease 12/2005
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2005
1	3-Hydroxyacyl-CoA Dehydrogenase Deficiency 03/2003
1	Activated Protein C Resistance (APC Resistance) 03/2003
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2003
1	Neoplasms (Cancer) 03/2003
1	Chronic Hepatitis (Chronic Active Hepatitis) 09/2001
1	Liver Diseases (Liver Disease) 09/2001
1	Reinfection 08/2001

Drug/Important Bio-Agent (IBA)

15	Hepatitis B e AntigensIBA 01/2018 - 10/2000
4	Lamivudine (Epivir)FDA Link 02/2015 - 10/2000
4	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 09/2001
4	Alanine Transaminase (SGPT)IBA 11/2010 - 10/2000
4	Interferon-alpha (Interferon Alfa)IBA 03/2005 - 02/2001
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2010 - 01/2008
3	Antiviral Agents (Antivirals)IBA 07/2010 - 03/2003
3	InterferonsIBA 05/2009 - 05/2001
2	Transaminases (Aminotransferases)IBA 02/2016 - 01/2004
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2008 - 05/2006
1	peginterferon alfa-2a (Pegasys)FDA Link 01/2018
1	MineralsIBA 07/2017
1	entecavir FDA Link 02/2015
1	Immunoglobulins (Immunoglobulin)IBA 02/2013
1	hepatitis B hyperimmune globulinIBA 02/2013
1	NucleotidesIBA 11/2012
1	Messenger RNA (mRNA)IBA 11/2010
1	IronIBA 11/2010
1	HepcidinsIBA 11/2010
1	Ferritins (Ferritin)IBA 11/2010
1	Anti-Idiotypic AntibodiesIBA 07/2010
1	Methotrexate (Mexate)FDA LinkGeneric 07/2010
1	RNA (Ribonucleic Acid)IBA 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 06/2009
1	CaspasesIBA 04/2008
1	Keratin-18 (Keratin 18)IBA 04/2008
1	Therapeutic UsesIBA 05/2007
1	Factor VIIa (Activated Factor VII)IBA 05/2007
1	Factor VIII (Coagulation Factor VIII)IBA 05/2007
1	recombinant FVIIa (rFVIIa)FDA Link 05/2007
1	Vasoconstrictor AgentsIBA 08/2006
1	Triglycerides (Triacylglycerol)IBA 05/2006
1	ethyl 4-chloro-3-hydroxybutanoate (CHBE)IBA 01/2006
1	CreatinineIBA 12/2005
1	Ribavirin (Virazole)FDA LinkGeneric 07/2004
1	adefovirIBA 01/2004
1	Immunomodulating AgentsIBA 01/2004
1	adefovir dipivoxil (Hepsera)FDA Link 01/2004
1	Antithrombin IIIIBA 03/2003
1	PlasminogenIBA 03/2003
1	Protein CIBA 03/2003
1	Immunoglobulin M (IgM)IBA 09/2001
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2001
1	Immunologic Factors (Immunomodulators)IBA 08/2000

Therapy/Procedure

10	Therapeutics 11/2012 - 10/2000
5	Liver Transplantation 02/2013 - 08/2000
1	Sclerotherapy 08/2006
1	Ligation 08/2006
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 07/2006
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 12/2005
1	Aftercare (After-Treatment) 07/2004